Bayesian Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,200
| Closed | -$111K | – | 816 |
|
|
2025
Q1 | $111K | Buy |
+14,200
| New | +$111K | 0.02% | 537 |
|
|
2024
Q3 | – | Sell |
-24,100
| Closed | -$367K | – | 981 |
|
|
2024
Q2 | $367K | Buy |
+24,100
| New | +$367K | 0.04% | 453 |
|
|
2022
Q3 | – | Sell |
-13,736
| Closed | -$348K | – | 967 |
|
|
2022
Q2 | $348K | Buy |
+13,736
| New | +$348K | 0.06% | 430 |
|